Clinical Microbiology and Antimicrobial Chemotherapy. 2018; 20(4):354-361
Ceftolozane/tazobactam is a new combined antibacterial agent for the treatment of infections caused by gram-negative microorganisms, P. aeruginosa in particular, including strains resistant to other clinically available antimicrobials. In this paper …